(0.20%) 5 110.17 points
(0.28%) 38 346 points
(0.09%) 15 942 points
(-0.38%) $83.53
(2.44%) $1.970
(-0.08%) $2 345.40
(-0.42%) $27.42
(2.61%) $946.15
(0.04%) $0.935
(-0.02%) $11.02
(-0.20%) $0.799
(1.92%) $93.64
4.86% $ 1.980
@ $11.19
Emitido: 13 feb 2024 @ 10:58
Retorno: -82.31%
Live Chart Being Loaded With Signals
eFFECTOR Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of selective translation regulator inhibitors for the treatment of cancer...
Stats | |
---|---|
Volumen de hoy | 12 050.00 |
Volumen promedio | 382 382 |
Capitalización de mercado | 7.30M |
EPS | $-3.42 ( 2024-03-27 ) |
Próxima fecha de ganancias | ( $-2.17 ) 2024-05-14 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.120 |
ATR14 | $0.0140 (0.73%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-02-19 | Loewy Caroline M | Buy | 2 000 | Stock Option (Right to Buy) |
2024-02-19 | Bhatt Elizabeth | Buy | 2 000 | Stock Option (Right to Buy) |
2024-02-19 | Ehrlich Christopher B | Buy | 2 000 | Stock Option (Right to Buy) |
2024-02-19 | Klencke Barbara | Buy | 2 000 | Stock Option (Right to Buy) |
2024-02-19 | Harrington-smith Kristen | Buy | 2 000 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
45.06 |
Last 95 transactions |
Buy: 5 541 401 | Sell: 1 016 887 |
Volumen Correlación
eFFECTOR Therapeutics, Correlación
10 Correlaciones Más Positivas | |
---|---|
APOP | 0.91 |
FLGT | 0.875 |
PIII | 0.875 |
PRSR | 0.871 |
MAGS | 0.871 |
SOFIW | 0.867 |
CMLF | 0.867 |
LPTX | 0.864 |
AGCUU | 0.863 |
WKSP | 0.863 |
10 Correlaciones Más Negativas | |
---|---|
ULTA | -0.855 |
IEP | -0.845 |
TNDM | -0.833 |
IART | -0.83 |
ASO | -0.829 |
CDAK | -0.828 |
IQ | -0.827 |
PAYS | -0.827 |
SBNYP | -0.817 |
PHCF | -0.815 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
eFFECTOR Therapeutics, Correlación - Moneda/Commodity
eFFECTOR Therapeutics, Finanzas
Annual | 2023 |
Ingresos: | $0 |
Beneficio Bruto: | $-111 000 (0.00 %) |
EPS: | $-16.37 |
FY | 2023 |
Ingresos: | $0 |
Beneficio Bruto: | $-111 000 (0.00 %) |
EPS: | $-16.37 |
FY | 2022 |
Ingresos: | $3.55M |
Beneficio Bruto: | $3.50M (98.51 %) |
EPS: | $-7.85 |
FY | 2021 |
Ingresos: | $0.00 |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $1.050 |
Financial Reports:
No articles found.
eFFECTOR Therapeutics,
eFFECTOR Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of selective translation regulator inhibitors for the treatment of cancer. Its lead product candidate is Tomivosertib, an oral small-molecule inhibitor of MNK that is in phase 2b clinical trial for the treatment of patients with metastatic non-small cell lung cancer. The company is also developing Zotatifin, a small molecule designed to inhibit eukaryotic initiation factor 4A (eIF4E), which is in phase 2clinical trial to treat patients with solid tumors. It has a collaboration agreement with Pfizer Inc. to develop inhibitors of eIF4E. eFFECTOR Therapeutics, Inc. was founded in 2012 and is headquartered in Solana Beach, California.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico